Emily Blodget

469 total citations
23 papers, 304 citations indexed

About

Emily Blodget is a scholar working on Epidemiology, Infectious Diseases and Oncology. According to data from OpenAlex, Emily Blodget has authored 23 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 10 papers in Infectious Diseases and 4 papers in Oncology. Recurrent topics in Emily Blodget's work include Antifungal resistance and susceptibility (5 papers), Cytomegalovirus and herpesvirus research (5 papers) and COVID-19 Clinical Research Studies (4 papers). Emily Blodget is often cited by papers focused on Antifungal resistance and susceptibility (5 papers), Cytomegalovirus and herpesvirus research (5 papers) and COVID-19 Clinical Research Studies (4 papers). Emily Blodget collaborates with scholars based in United States, Thailand and Switzerland. Emily Blodget's co-authors include Michael Laposata, Samir K. Gupta, James H. Stein, Changyu Shen, Grace M. Aldrovandi, Adrienne Rollie, Michael P. Dubé, Robert A. Larsen, Paolo M. Suter and P. Jan Geiseler and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Clinical Chemistry.

In The Last Decade

Emily Blodget

23 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily Blodget United States 11 116 104 52 47 43 23 304
Tomoko Uehira Japan 12 212 1.8× 131 1.3× 50 1.0× 5 0.1× 62 1.4× 54 475
Marie Lagrange-Xélot France 10 184 1.6× 108 1.0× 30 0.6× 6 0.1× 33 0.8× 27 369
Enrique Cornejo Cisneros United States 5 143 1.2× 61 0.6× 65 1.3× 18 0.4× 4 0.1× 9 301
J Prazák Switzerland 10 46 0.4× 116 1.1× 34 0.7× 124 2.6× 6 0.1× 29 334
Albert Dompreh Ghana 12 201 1.7× 105 1.0× 31 0.6× 6 0.1× 13 0.3× 35 367
Tara L. Anderson United States 14 398 3.4× 176 1.7× 98 1.9× 7 0.1× 44 1.0× 26 696
Trevor Kaile Zambia 9 172 1.5× 114 1.1× 34 0.7× 3 0.1× 11 0.3× 28 307
Emilia Zicca Italy 9 62 0.5× 102 1.0× 85 1.6× 28 0.6× 6 0.1× 11 255
Ya‐Shu Chang Taiwan 10 92 0.8× 166 1.6× 99 1.9× 15 0.3× 19 0.4× 13 355
Farina Karim South Africa 16 377 3.3× 228 2.2× 66 1.3× 24 0.5× 3 0.1× 38 551

Countries citing papers authored by Emily Blodget

Since Specialization
Citations

This map shows the geographic impact of Emily Blodget's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Blodget with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Blodget more than expected).

Fields of papers citing papers by Emily Blodget

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Blodget. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Blodget. The network helps show where Emily Blodget may publish in the future.

Co-authorship network of co-authors of Emily Blodget

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Blodget. A scholar is included among the top collaborators of Emily Blodget based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Blodget. Emily Blodget is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Benjamin J., Hannah Nam, Deepa Jeyakumar, et al.. (2024). Persistent Impairment in Immune Reconstitution and Worse Survival Outcomes in Allogeneic Stem Cell Transplantation Patients with Early Coronavirus Disease 2019 Infection. Transplantation and Cellular Therapy. 30(8). 816.e1–816.e10. 2 indexed citations
2.
Lee, Benjamin J., Julie Smith, Hannah Nam, et al.. (2024). Extending duration of letermovir prophylaxis in haploidentical stem cell transplantation. Haematologica. 109(11). 3806–3810. 1 indexed citations
3.
Lee, Benjamin J., Hannah Nam, Emily Blodget, et al.. (2023). Once-Daily Foscarnet Is Effective for Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 29(6). 397.e1–397.e6. 7 indexed citations
4.
Green, Sabrina I., Justin R. Clark, Keiko C. Salazar, et al.. (2023). A Retrospective, Observational Study of 12 Cases of Expanded-Access Customized Phage Therapy: Production, Characteristics, and Clinical Outcomes. Clinical Infectious Diseases. 77(8). 1079–1091. 56 indexed citations
5.
Yaghmour, George, et al.. (2021). Comparing Outcomes of Different Anti-Fungal Therapies As Invasive Fungal Infection Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients. Transplantation and Cellular Therapy. 27(3). S364–S364. 1 indexed citations
6.
Domínguez, Fernándo & Emily Blodget. (2020). Multidrug-resistant bacteria in lung transplantation. Current Opinion in Organ Transplantation. 25(4). 348–350. 4 indexed citations
7.
Rosen, Hugo R., Casey L. O’Connell, Mitra K. Nadim, et al.. (2020). Extrapulmonary manifestations of severe acute respiratory syndrome coronavirus‐2 infection. Journal of Medical Virology. 93(5). 2645–2653. 13 indexed citations
8.
Blodget, Emily, et al.. (2020). Remdesivir for the Treatment of COVID-19: A Systematic Review of the Literature. Western Journal of Emergency Medicine. 21(4). 737–741. 16 indexed citations
9.
Chang, Jeremy, et al.. (2019). <p>Increased risk of 100-day and 1-year infection-related mortality and complications in haploidentical stem cell transplantation</p>. Journal of Blood Medicine. Volume 10. 135–143. 14 indexed citations
10.
Domínguez, Fernándo & Emily Blodget. (2019). Community-acquired respiratory viruses. Current Opinion in Organ Transplantation. 24(4). 511–514. 3 indexed citations
11.
Blodget, Emily, et al.. (2019). VRE in cirrhotic patients. BMC Infectious Diseases. 19(1). 711–711. 15 indexed citations
12.
Blodget, Emily, et al.. (2019). A Comparison of Aspergillus Prophylaxis with Voriconazole versus Isavuconazole in Lung Transplant Recipients. The Journal of Heart and Lung Transplantation. 38(4). S118–S119. 1 indexed citations
13.
Blodget, Emily, et al.. (2019). Coccidioidomycosis in solid organ transplant recipients. Current Opinion in Organ Transplantation. 24(4). 465–468. 6 indexed citations
14.
Wald‐Dickler, Noah & Emily Blodget. (2017). Cryptococcal disease in the solid organ transplant setting. Current Opinion in Organ Transplantation. 22(4). 307–313. 9 indexed citations
15.
Blodget, Emily, et al.. (2017). Treatment of Carbapenem-Resistant Enterobacteriaceae Infections with Ceftazidime-Avibactam. Open Forum Infectious Diseases. 4(suppl_1). S286–S286. 1 indexed citations
16.
Gokoffski, Kimberly K., James Hu, Emily Blodget, et al.. (2017). Treatment of multifocal central nervous system AIDS-related Epstein Barr virus-associated malignant myopericytoma with bevacizumab. 4(3). 121–127. 4 indexed citations
17.
Cantey, Paul T., et al.. (2013). Reactivation of Chagas disease in a bone marrow transplant patient: case report and review of screening and management. Transplant Infectious Disease. 15(6). E264–7. 16 indexed citations
18.
Blodget, Emily, Changyu Shen, Grace M. Aldrovandi, et al.. (2012). Relationship between Microbial Translocation and Endothelial Function in HIV Infected Patients. PLoS ONE. 7(8). e42624–e42624. 40 indexed citations
19.
Blodget, Emily, et al.. (2011). Donor‐derived Coccidioides immitis fungemia in solid organ transplant recipients. Transplant Infectious Disease. 14(3). 305–310. 28 indexed citations
20.
Sicińska, Ewa, et al.. (1999). Preanalytical Variables Affecting the Quantification of Fatty Acid Ethyl Esters in Plasma and Serum Samples. Clinical Chemistry. 45(12). 2183–2190. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomoko Uehira Breakdown of academic impact, for papers by Marie Lagrange-Xélot Breakdown of academic impact, for papers by Enrique Cornejo Cisneros Breakdown of academic impact, for papers by J Prazák Breakdown of academic impact, for papers by Albert Dompreh Breakdown of academic impact, for papers by Tara L. Anderson Breakdown of academic impact, for papers by Trevor Kaile Breakdown of academic impact, for papers by Emilia Zicca Breakdown of academic impact, for papers by Ya‐Shu Chang Breakdown of academic impact, for papers by Farina Karim
Rankless by CCL
2026